by admin | Sep 9, 2023 | News & Opinions
By Paul Sisson – The San Diego Tribune A newly announced $5 million donation to UC San Diego that will support a new gene therapy initiative illustrates the value of making good on big promises. The contribution is the latest from philanthropists Nancy and Jeff...
by admin | Sep 8, 2023 | News & Opinions
By Grace Niewijk – University of Chicago Medicine New research published in the New England Journal of Medicine indicates that stem cell gene therapy may offer a promising, curative treatment for the painful, inherited blood disorder sickle cell disease (SCD)....
by admin | Sep 7, 2023 | News & Opinions
by Sarah Anderson, PhD – Exploring Drug Discovery and Development Like a differentiated stem cell, Lonnie Shea’s strong foundation in fundamental cellular biology underwent just the right prompts to evolve into a proliferative biomedical research career. During...
by admin | Sep 6, 2023 | News & Opinions
by Massachusetts Eye and Ear Infirmary A team led by researchers from Mass Eye and Ear, a member of Mass General Brigham, reports the results of a phase I trial of a revolutionary stem cell treatment called cultivated autologous limbal epithelial cell transplantation...
by admin | Sep 5, 2023 | News & Opinions
By Florina Gobel – Center for Contemporary Sciences In the article Human disease models in drug development published in Nature, the authors delve into the critical role of human disease models in drug development, emphasizing the importance of bridging the gap...
by admin | Sep 1, 2023 | News & Opinions
By Drug Target Review Using genetically modified human neural stem cells (hNSCs), researchers demonstrated that targeted manipulation of a specific gene expression within hNSCs can facilitate the restoration of damaged neural circuits and recovery of locomotor...
